Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Reconsidering the Consequences of Using Race to Estimate Kidney Function.

Eneanya ND, Yang W, Reese PP.

JAMA. 2019 Jun 6. doi: 10.1001/jama.2019.5774. [Epub ahead of print] No abstract available.

PMID:
31169890
2.

The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies.

Putt ME, Reese PP, Volpp KG, Russell LB, Loewenstein G, Yan J, Pagnotti D, McGilloway R, Brennen T, Finnerty D, Hoffer K, Chadha S, Barankay I.

Clin Trials. 2019 May 31:1740774519846852. doi: 10.1177/1740774519846852. [Epub ahead of print]

PMID:
31148473
3.

High multiplicity infection following transplantation of hepatitis C virus-positive organs.

Zahid MN, Wang S, Learn GH, Abt PL, Blumberg EA, Reese PP, Goldberg DS, Shaw GM, Bar KJ.

J Clin Invest. 2019 May 21;130. pii: 127203. doi: 10.1172/JCI127203.

4.

Quality measures, all-cause mortality, and healthcare utilization in a national cohort of Veterans with cirrhosis.

Serper M, Kaplan DE, Shults J, Reese PP, Beste LA, Taddei TH, Werner RM.

Hepatology. 2019 May 20. doi: 10.1002/hep.30779. [Epub ahead of print]

PMID:
31107967
5.

Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes.

Sonnenberg EM, Cohen JB, Hsu JY, Potluri VS, Levine MH, Abt PL, Reese PP.

Am J Kidney Dis. 2019 May 7. pii: S0272-6386(19)30635-3. doi: 10.1053/j.ajkd.2019.02.019. [Epub ahead of print]

PMID:
31076173
6.

Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ.

Porrett PM, Reese PP, Holzmayer V, Coller KE, Kuhns M, Van Deerlin VM, Gentile C, Smith JR, Sicilia A, Woodards A, McLean R, Abt P, Bloom RD, Reddy KR, Blumberg E, Cloherty G, Goldberg D.

Am J Transplant. 2019 May 7. doi: 10.1111/ajt.15415. [Epub ahead of print]

PMID:
31066215
7.

Frailty and Cognitive Deficits Limit Access to Kidney Transplantation: Unfair or Unavoidable?

Harhay MN, Reese PP.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):493-495. doi: 10.2215/CJN.02390219. Epub 2019 Mar 19. No abstract available.

PMID:
30890579
8.

Characterization of early hepatic injury in HCV-negative recipients of HCV-infected kidneys.

Mazur RD, Abt PL, Blumberg EA, Bloom RD, Reddy KR, Reese PP, Goldberg DS.

Clin Transplant. 2019 Apr;33(4):e13494. doi: 10.1111/ctr.13494. Epub 2019 Mar 6. No abstract available.

PMID:
30779252
9.

Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial.

McLean RC, Reese PP, Acker M, Atluri P, Bermudez C, Goldberg LR, Abt PL, Blumberg EA, Van Deerlin VM, Reddy KR, Bloom RD, Hasz R, Suplee L, Sicilia A, Woodards A, Zahid MN, Bar KJ, Porrett P, Levine MH, Hornsby N, Gentile C, Smith J, Goldberg DS.

Am J Transplant. 2019 Feb 15. doi: 10.1111/ajt.15311. [Epub ahead of print]

PMID:
30768838
10.

Leveraging marginal structural modeling with Cox regression to assess the survival benefit of accepting vs declining kidney allograft offers.

Cohen JB, Potluri V, Porrett PM, Chen R, Roselli M, Shults J, Sawinski DL, Reese PP.

Am J Transplant. 2019 Feb 6. doi: 10.1111/ajt.15290. [Epub ahead of print]

PMID:
30725536
11.

Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

Sawinski D, Forde KA, Lo Re V 3rd, Goldberg DS, Cohen JB, Locke JE, Bloom RD, Brensinger C, Weldon J, Shults J, Reese PP.

Am J Kidney Dis. 2019 Jun;73(6):815-826. doi: 10.1053/j.ajkd.2018.11.009. Epub 2019 Jan 29.

PMID:
30704882
12.

Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant.

Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE.

Am J Transplant. 2019 Jun;19(6):1806-1819. doi: 10.1111/ajt.15239. Epub 2019 Jan 25.

PMID:
30589503
13.

Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.

Cohen JB, Locke JE, Shelton B, Reed RD, Mustian M, MacLennan P, Forde KA, Reese PP, Sawinski D.

Clin Transplant. 2019 Feb;33(2):e13466. doi: 10.1111/ctr.13466. Epub 2019 Jan 12.

PMID:
30578590
14.
15.

Deceased-donor acute kidney injury is not associated with kidney allograft failure.

Hall IE, Akalin E, Bromberg JS, Doshi MD, Greene T, Harhay MN, Jia Y, Mansour SG, Mohan S, Muthukumar T, Reese PP, Schröppel B, Singh P, Thiessen-Philbrook HR, Weng FL, Parikh CR.

Kidney Int. 2019 Jan;95(1):199-209. doi: 10.1016/j.kint.2018.08.047. Epub 2018 Nov 20.

PMID:
30470437
16.

Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function.

Schröppel B, Heeger PS, Thiessen-Philbrook H, Hall IE, Doshi MD, Weng FL, Reese PP, Parikh CR.

Transplantation. 2019 Jan;103(1):e29-e35. doi: 10.1097/TP.0000000000002494.

PMID:
30451738
17.

Reliability of deceased-donor procurement kidney biopsy images uploaded in United Network for Organ Sharing.

Mansour SG, Hall IE, Reese PP, Jia Y, Thiessen-Philbrook H, Moeckel G, Weng FL, Revelo MP, Khalighi MA, Trivedi A, Doshi MD, Schröppel B, Parikh CR.

Clin Transplant. 2018 Dec;32(12):e13441. doi: 10.1111/ctr.13441. Epub 2018 Dec 6.

PMID:
30387908
18.

Informative for Decision Making? The Spectrum and Consistency of Outcomes After Living Kidney Donation Reported in Trials and Observational Studies.

Hanson CS, Sautenet B, Craig JC, Chapman JR, Knoll G, Reese PP, Tong A.

Transplantation. 2019 Feb;103(2):284-290. doi: 10.1097/TP.0000000000002489.

PMID:
30335693
19.

Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival.

Hall IE, Parikh CR, Schröppel B, Weng FL, Jia Y, Thiessen-Philbrook H, Reese PP, Doshi MD.

Transplant Direct. 2018 Jul 16;4(8):e373. doi: 10.1097/TXD.0000000000000816. eCollection 2018 Aug.

20.

Outcomes for individuals turned down for living kidney donation.

Reese PP, Allen MB, Carney C, Leidy D, Levsky S, Pendse R, Mussell AS, Bermudez F, Keddem S, Thiessen C, Rodrigue JR, Emanuel EJ.

Clin Transplant. 2018 Dec;32(12):e13408. doi: 10.1111/ctr.13408. Epub 2018 Oct 28.

PMID:
30218994
21.

Imminent Death Donation: Beyond Ethical Analysis and into Practice.

Lee GS, Potluri VS, Reese PP.

J Law Med Ethics. 2018 Jun;46(2):538-540. doi: 10.1177/1073110518782962. No abstract available.

PMID:
30146978
22.

Racial Disparities in Nephrology Consultation and Disease Progression among Veterans with CKD: An Observational Cohort Study.

Suarez J, Cohen JB, Potluri V, Yang W, Kaplan DE, Serper M, Shah SP, Reese PP.

J Am Soc Nephrol. 2018 Oct;29(10):2563-2573. doi: 10.1681/ASN.2018040344. Epub 2018 Aug 17.

PMID:
30120108
23.

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.

Reese PP, Abt PL, Blumberg EA, Van Deerlin VM, Bloom RD, Potluri VS, Levine M, Porrett P, Sawinski D, Nazarian SM, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Gentile C, Smith J, Niknam BA, Bleicher M, Reddy KR, Goldberg DS.

Ann Intern Med. 2018 Sep 4;169(5):273-281. doi: 10.7326/M18-0749. Epub 2018 Aug 7.

PMID:
30083748
24.

Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.

Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE.

Am J Transplant. 2018 Oct;18(10):2483-2495. doi: 10.1111/ajt.15040. Epub 2018 Aug 30.

25.

New Insights Into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney Transplant.

Goldberg DS, Reese PP.

Ann Intern Med. 2018 Aug 21;169(4):256-257. doi: 10.7326/M18-1718. Epub 2018 Jul 10. No abstract available.

PMID:
29987318
26.

Range and Consistency of Outcomes Reported in Randomized Trials Conducted in Kidney Transplant Recipients: A Systematic Review.

Sautenet B, Tong A, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Evangelidis N, Craig JC.

Transplantation. 2018 Dec;102(12):2065-2071. doi: 10.1097/TP.0000000000002278.

PMID:
29781954
27.

Cognitive Impairment in Non-Dialysis-Dependent CKD and the Transition to Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Harhay MN, Xie D, Zhang X, Hsu CY, Vittinghoff E, Go AS, Sozio SM, Blumenthal J, Seliger S, Chen J, Deo R, Dobre M, Akkina S, Reese PP, Lash JP, Yaffe K, Kurella Tamura M; CRIC Study Investigators.

Am J Kidney Dis. 2018 Oct;72(4):499-508. doi: 10.1053/j.ajkd.2018.02.361. Epub 2018 May 2.

PMID:
29728316
28.

Kidney transplant outcomes: Position in the match-run does not seem to matter beyond other donor risk factors.

Cohen JB, Shults J, Goldberg DS, Abt PL, Sawinski DL, Reese PP.

Am J Transplant. 2018 Jun;18(6):1577-1578. doi: 10.1111/ajt.14883. Epub 2018 May 11. No abstract available.

29.

Impact of prolonged dialysis prior to renal transplantation.

Aufhauser DD Jr, Peng AW, Murken DR, Concors SJ, Abt PL, Sawinski D, Bloom RD, Reese PP, Levine MH.

Clin Transplant. 2018 Jun;32(6):e13260. doi: 10.1111/ctr.13260. Epub 2018 Jun 25.

PMID:
29656398
30.

The association of discharge decisions after deceased donor kidney transplantation with the risk of early readmission: Results from the deceased donor study.

Harhay MN, Jia Y, Thiessen-Philbrook H, Besharatian B, Gumber R, Weng FL, Hall IE, Doshi M, Schroppel B, Parikh CR, Reese PP.

Clin Transplant. 2018 Apr;32(4):e13215. doi: 10.1111/ctr.13215. Epub 2018 Mar 3.

31.

The Quest to Define Individual Risk After Living Kidney Donation.

Poggio ED, Reese PP.

Ann Intern Med. 2018 Feb 20;168(4):296-297. doi: 10.7326/M17-3249. Epub 2018 Jan 30. No abstract available.

PMID:
29379960
32.

Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant.

McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, Doshi SD, Abt P, Bloom R, Blumberg E, Kulkarni S, Esnaola G, Shults J, Thiessen C, Reese PP.

Transplantation. 2018 Apr;102(4):e163-e170. doi: 10.1097/TP.0000000000002099.

PMID:
29346260
33.

Hepatitis C virus genotyping of organ donor samples to aid in transplantation of HCV-positive organs.

Gentile C, Van Deerlin VM, Goldberg DS, Reese PP, Hasz RD, Abt P, Blumberg E, Farooqi MS.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13172. Epub 2017 Dec 21.

PMID:
29220079
34.

The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study.

Serper M, Reese PP, Patzer RR, Levitsky J, Wolf MS.

Transpl Int. 2018 Aug;31(8):870-879. doi: 10.1111/tri.13098. Epub 2017 Dec 15.

PMID:
29178601
35.

Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.

Sawinski D, Forde KA, Locke JE, Cohen JB, Weldon J, Shults J, Reese PP.

Kidney Int. 2018 Mar;93(3):706-715. doi: 10.1016/j.kint.2017.08.015. Epub 2017 Oct 26.

PMID:
29107361
36.

Transplanting HCV-Infected Kidneys into Uninfected Recipients.

Goldberg DS, Abt PL, Reese PP; THINKER Trial Investigators.

N Engl J Med. 2017 Sep 14;377(11):1105. doi: 10.1056/NEJMc1709315. No abstract available.

PMID:
28902585
37.

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.

BMJ Open Diabetes Res Care. 2017 Jul 31;5(1):e000400. doi: 10.1136/bmjdrc-2017-000400. eCollection 2017.

38.

Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.

Moledina DG, Hall IE, Thiessen-Philbrook H, Reese PP, Weng FL, Schröppel B, Doshi MD, Wilson FP, Coca SG, Parikh CR.

Am J Kidney Dis. 2017 Dec;70(6):807-816. doi: 10.1053/j.ajkd.2017.06.031. Epub 2017 Aug 24.

39.

The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing.

Laskin BL, Jiao J, Baluarte HJ, Amaral S, Furth SL, Akimova T, Hancock WW, Levine MH, Reese PP, Beier UH.

Transplant Direct. 2017 Jul 19;3(8):e199. doi: 10.1097/TXD.0000000000000715. eCollection 2017 Aug.

40.

Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival.

Cohen JB, Shults J, Goldberg DS, Abt PL, Sawinski DL, Reese PP.

Am J Transplant. 2018 Feb;18(2):391-401. doi: 10.1111/ajt.14449. Epub 2017 Sep 2.

41.

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.

Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC.

Transplantation. 2017 Aug;101(8):1875-1886. doi: 10.1097/TP.0000000000001776.

42.

Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.

Tong A, Gill J, Budde K, Marson L, Reese PP, Rosenbloom D, Rostaing L, Wong G, Josephson MA, Pruett TL, Warrens AN, Craig JC, Sautenet B, Evangelidis N, Ralph AF, Hanson CS, Shen JI, Howard K, Meyer K, Perrone RD, Weiner DE, Fung S, Ma MKM, Rose C, Ryan J, Chen LX, Howell M, Larkins N, Kim S, Thangaraju S, Ju A, Chapman JR; SONG-Tx Investigators.

Transplantation. 2017 Aug;101(8):1887-1896. doi: 10.1097/TP.0000000000001774.

43.

Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.

Mansour SG, Puthumana J, Reese PP, Hall IE, Doshi MD, Weng FL, Schröppel B, Thiessen-Philbrook H, Bimali M, Parikh CR.

Kidney Int Rep. 2017 Jul;2(4):749-758. doi: 10.1016/j.ekir.2017.03.007. Epub 2017 Mar 31.

44.

Dialysis Payment Model Reform: Managing Conflicts Between Profits and Patient Goals of Care Decision Making.

Berns JS, Glickman JD, Reese PP.

Am J Kidney Dis. 2018 Jan;71(1):133-136. doi: 10.1053/j.ajkd.2017.04.024. Epub 2017 Jun 26. No abstract available.

PMID:
28663064
45.

Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.

Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP, Sawinski DL.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):974-982. doi: 10.2215/CJN.10280916. Epub 2017 May 25.

46.

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Goldberg DS, Abt PL, Blumberg EA, Van Deerlin VM, Levine M, Reddy KR, Bloom RD, Nazarian SM, Sawinski D, Porrett P, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Farooqi M, Gentile C, Smith J, Reese PP.

N Engl J Med. 2017 Jun 15;376(24):2394-2395. doi: 10.1056/NEJMc1705221. Epub 2017 Apr 30. No abstract available.

PMID:
28459186
47.

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP.

J Am Soc Nephrol. 2017 Jul;28(7):2188-2200. doi: 10.1681/ASN.2016070768. Epub 2017 Mar 20.

48.

Hemodialysis Clinic Social Networks, Sex Differences, and Renal Transplantation.

Gillespie A, Fink EL, Traino HM, Uversky A, Bass SB, Greener J, Hunt J, Browne T, Hammer H, Reese PP, Obradovic Z.

Am J Transplant. 2017 Sep;17(9):2400-2409. doi: 10.1111/ajt.14273. Epub 2017 Apr 21.

49.

Sense and sensitivity: incompatible patients and their donors in kidney transplantation.

Reese PP, Mohan S.

Lancet. 2017 Feb 18;389(10070):677-678. doi: 10.1016/S0140-6736(16)32053-0. Epub 2017 Jan 6. No abstract available.

PMID:
28065560
50.

The case against imminent death donation.

Lee GS, Potluri VS, Reese PP.

Curr Opin Organ Transplant. 2017 Apr;22(2):184-188. doi: 10.1097/MOT.0000000000000389. Review.

PMID:
28030433

Supplemental Content

Loading ...
Support Center